Just over a week left to register! Look forward to seeing you there.
There's a little over a week to get your ticket to the 2024 Innovation Showcase on May 22 at Scripps Research. Hear from our awesome #venturecapital panel featuring Jeremy Caldwell, Joe Gatto, Benjamin Kim and Liang Song, moderated by Jason Novak. Thanks to Norton Rose Fulbright for sponsoring this amazing group of investors who are helping to keep #sandiego #innovation strong. Get tickets at https://lnkd.in/gMhZbq9E
Where are the nudges? Where are the tiny shifts in how we design the interactions in the funding process that create the kind of inclusive culture that leads to more funding equity? I bet there are already lots of examples of new ways of working that individuals and organizations are already testing. At the LabCentral Funding Innovation Lab, we want to help prove the efficacy through our experimentation model and then help scale and amplify these new best practices. Come join the conversation! https://lnkd.in/geAJ6XrS
Can you imagine a quantitative study delving into the world of corporate<>startup collaboration (#VentureClienting)? Well, mark your calendars because from the 📆 13th of February, it's happening! Excited to be part of this groundbreaking event or itching to get your hands on the report? Don't hesitate to reach out to me directly—I've got you covered to explore the future of corporate<>startup dynamics in an immersive way!
💥 Happy 2024 innovators, 📆 13th of February we will launch the first of it's kind quantitative study 🤯 on corporate<>startup collaboration (Venture Clienting) together with Digital Hub Initiative. Come join us! 👩💻We collected and analysed over 80k relationship data points (e.g. Bosch & Synthesia) and were able to draw significant conclusions. 👩🏫 Complemented by expert articles and perspectives from Brigitte Zypries, Dietmar Harhoff, Peter Borchers, Christian Lindener 🥷, Jens Hofmeister, Harsh Shah, Christian Hüttenhein, Tobias Gutmann, Gleb Tritus, Florian Noell, Philipp B. Pilat, Jutta Jakobi, Katharina Götzen, Ronja Stoffregen, Nicolai Heinzelmann, Philipp Willigmann, Lars Roessler, Prof. Dr. Theresa Treffers, Isabell Welpe, Matthias Notz, Claus J. Karthe, Suraj from Humanising Autonomy, Sabine Wiesmüller, PhD, Eileen W. Teodora Georgieva, David Heller, Daehyun Kim 📍Get your tickets and early access to the study here: https://lnkd.in/eiQw-bKF
Chief Executive, UK & Ireland @IBM | Deputy President @TechUK | NED @Drax Group plc & @Beazley Group plc |
Great strides ahead in the science and technology sector this week👏🏼. I had the opportunity to hear first-hand from Michelle Donelan MP who announced the Department for Science, Innovation and Technology #ScaleUPUK vision to back scale-ups, boost skills and regulate to support innovation. Scale-ups often face limited resources and are confused by the regulatory landscape, or lack the right talent and opportunities to access large markets and get going. However, this new scale-up forum will bring together leading figures from across the growing science and technology sector and provide the necessary support to help them unblock the key issues getting in the way of their high-growth ambitions. This, alongside the commitment to become a Science and Tech superpower by 2030, will enrich our communities and our businesses, and fuel economic growth across the country. #innovation #ukeconomy
Global Waste Lead, Global EHS at 3M Corporate Environment, Health, Safety and Product Stewardship. Board Chairman, CHWMEG, Inc.
Jayshree Seth, 3M's Chief Science Advocate, discusses the importance of innovation, resilience, and curiosity. In this interview with TomorrowZone Catalyst, she highlights the role of innovation in empowering teams, her vision for sustainable innovation, and the need to blend social sciences with technology. #3Mer https://dy.si/VuJTMT
😀 🚀 Good news! CrowdScan secures new funding of just under 1 million euros. In addition to extra personal contributions from the co-founders, we receive an injection of 500,000 euros. The fresh capital comes from imec.istart and new external shareholders, such as Yves De Laere, and the investment fund Euphoria represented by Alex Moreels. They strengthen the existing team of investors, which includes Qbic Fund | Venture Capital and Wim Bijnens Over the past year, we have invested heavily in making our technology more plug-and-play. Our various international projects and the rising demand from the Netherlands and Flanders clearly demonstrate a growing global need for reliable, privacy-friendly crowd data. We have proven to be relevant not only at events but also within smart cities and public transportation. Thanks to this new investment, we can further sustain our growth. #brightfuture #internationalgrowth #innovation #capitalinjection #investment
As companies evaluate where to put down roots, we have developed a white paper to help each company navigate the process and focus on what means the most for their organization. Please share and let us know your thoughts!
Fitzsimons Innovation Community presents a new white paper – Choosing an Innovation Community – from a group of thought leaders in the Colorado bioscience and economic development communities. This extensive report looks at the factors that go into choosing the right innovation community for life sciences companies of all sizes. Whether you’re looking to put down roots in Colorado or at one of the other innovation communities across the country, this white paper helps you navigate the process with a focus on what means the most to you and your organization. Read the full white paper here. https://lnkd.in/ghDnyX-7
Jayshree Seth, 3M's Chief Science Advocate, discusses the importance of innovation, resilience, and curiosity. In this interview with TomorrowZone Catalyst, she highlights the role of innovation in empowering teams, her vision for sustainable innovation, and the need to blend social sciences with technology. #3Mer https://dy.si/9M9Q39
Went to a very interesting event last night at a super trendy "house-office" in San Francisco with a killer view (Fifty Years Venture Capital - thanks to the team for hosting!) The night's theme centered on Decentralized Science (#DeSci). The aim of DeSci is to establish a system that funds and rewards scientists globally, irrespective of their institutional affiliations. DeSci is working on a system where good ideas can thrive by decentralizing access to funding, scientific resources, and communication channels[1]. Democratizing science is not a new concept. So how is DeSci actually pulling this off? It helps to zoom into a couple of companies in this space to get an idea: Molecule AG and BioCrowd.IO Despite some differences, the overarching concept remains consistent: Molecule and BioCrowd are establishing a way for funders (professional and retail) to fund researchers. They streamline the process by assisting with contracts, sponsored research agreements, and patent licenses. Ultimate goal is to expedite translational research (bridging "the valley of death") by offering researchers easier access to capital and simplifying the investment process for funders. Let me know if you are interested in a deeper dive 🙌
Why are strategic partnerships critical for life science innovation? Strategic partnerships between life science startups and large corporations are becoming increasingly vital for accelerating innovation and bringing new therapies to market. These collaborations provide a symbiotic relationship where startups gain access to resources, expertise, and infrastructure, while large companies tap into cutting-edge research and innovative ideas. Learn more about why strategic partnerships are critical for life science innovation > https://hubs.ly/Q02GhYhp0
Our Managing Partner, Tim Damgaard Christensen, had the opportunity to moderate a panel debate at today's LSX Nordic Congress. Good things happen when investors and strategics meet to share insights into how MedTech innovators and startups can partner for funding and/or acceleration. A couple of important points, for you as an innovator: - Make sure you approach partners that qualify as the "best future home" for your innovation. - Do your due diligence. Research potential strategic partners for best product fit, best strategy fit - and best cultural fit. Thanks for playing along and sharing your invaluable insights, Bo Vendelboe, Tejas Atawane, Emily Xiao Fu, CFA, and Thomas Hardahl - and thanks for the opportunity to learn, Josh Dance, and Caitlín McNally!
